The effect of treatment with a protease inhibitor on mycobacterial infection

Diagnostic Microbiology and Infectious Disease

Volumn 51, Issue 4, 2005, Pages 251-258

  Kabbesh, Mohammad ^a   Koomer, Ajoy ^a   Molteni, Agostino ^a   Amajoyi, Robert ^a   Quinn, Tim ^a   Herndon, Betty ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; M. bovis BCG; Protease inhibitors; Ritonavir

Indexed keywords

BCG VACCINE; CYTOKINE; PROTEINASE INHIBITOR; RITONAVIR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; BACTERIUM CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; GRANULOMA; INFECTION RESISTANCE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING; TISSUE CULTURE;

EID: 16244400807     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.11.016     Document Type: Article

References (30)

1. F.E. Aldwell, B. Dicker, F.M. da Silva-Tatley, M. Cross, S. Liggett, C.G. Mackintosh, and F.T. Griffin Mycobacterium bovis-infected cervine alveolar macrophages secrete lymphoreactive lipid antigens Infect. Immun. 68 2000 7003 7009
2. D.M. Bamberger, K. Eddens, B. Herndon, and S. Mullick Staphylococcus aureus penicillin binding proteins (PBPs). Identification by Western blot and anti-ampicillin monoclonal Abstract A-19 General Meeting of the American Society for Microbiology, Chicago, IL 1999 4
3. D.M. Bamberger, B.L. Herndon, J. Fitch, A. Florkowski, and V. Parkhurst The effect of neutrophils on cefazolin activity and penicillin binding proteins in Staphylococcus aureus abscesses Antimicrob. Agents. Chemother. 46 2002 2878 2884
4. W.L. Beatty, E.R. Rhoades, H.J. Ullrich, D. Chatterjee, J.E. Heuser, and D.G. Russell Trafficking and release of mycobacterial lipids from infected macrophages Traffic 1 2000 235 247
5. M. Brennan, G. Delogu, Y. Chen, S. Bardarov, J. Kriakov, M. Alavi, and W.R. Jacobs Jr. Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells Infect. Immun. 69 2001 7326 7333
6. J.A. Dave, N.C.G. vanPittius, A.D. Beyers, M.R.W. Ehlers, and D.B. Gordon Mycosin-1, a subtilisin-like serine protease of Mycobacterium tuberculosis, is cell wall-associated and expressed during infection of macrophages BMC Microbiol. 2 2002 30
7. H1 cytokines and the IL-4 antagonist IL-4delta2 J. Immunol. 172 2004 6938 6943
8. F. Denissen, B.A. Grabowski, M.K. Johnson, A.M. Buko, D.J. Kempf, S.B. Thomas, and B.W. Surber Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans Drug Metab. Dispos. 25 1997 489 501
9. N. Dhar, V. Rao, and A.K. Tyagi Skewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG system Immunol. Lett. 88 2003 175 184
10. V.J. Erb, C. Trujillio, and M. Fugate Infection with helminthes Nippostrongylus brasiliensis does not interfere with efficient elimination of M. bovis' BCG from lungs of mice Clin. Diagn. Lab. Immunol. 3 2003 727 730
11. L. Fattorini, G. Orefici, S.H. Jin, G. Scardaci, G. Amicosante, N. Franceschini, and I. Chopra Resistance to β-lactams in Mycobacterium fortuitum Antimicrob. Agents Chemother. 36 1992 1068 1072
12. R.J. Germanino Anti-retroviral protease inhibitors-'a two edged sword?' IUBMB Life 55 2003 67 70
13. T. Gooding, A. Kemp, R. Robins-Brown, M. Smith, and P.D.R. Johnson Acquired T-helper 1 lymphocyte anergy following infection with Mycobacterium ulcerans Clin. Infect. Dis. 36 2003 1076 1077
14. T.M. Gooding, P.D. Johnson, D.E. Campbell, J.A. Hayman, E.L. Hartland, A.S. Kemp, S. Robins-Hartman, and R. Lucius Modulation of host immune response by nematode cystatins Clin. Diagn. Lab. Immunol. 9 2002 727 730
15. Y. Kageyama, S. Kawakami, Y. Fuji, K. Kihara, and H. Oshima Bacillus Calmette-Guerin enhances production and secretion of type IV collagenases in peripheral blood mononuclear cells Jpn. J. Cancer Res. 88 1997 281 288
16. F. Kheradmand, A. Kiss, J. Xu, S.H. Lee, P.E. Kolattukudy, and D.B. Corry A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease J. Immunol. 169 2002 5904 5911
17. A. Koomer, S. Latcham, B. Herndon, and W. Gutheil A novel immune based study for the detection of microbial penicillin-binding proteins Poster T2074 American Association of Pharmaceutical Scientists, Toronto, Canada 2002
18. S.R. Krutzik, and R.L. Modlin The role of toll-like receptors in combating mycobacteria Semin. Immunol. 16 2004 35 41
19. P.A. Lambert Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria J. Appl. Microbiol. 92 Suppl. 2002 46S 54S
20. C. Mailaender, N. Reiling, H. Engelhardt, S. Bossmann, S. Ehlers, and M. Niederweis The MspA porin promotes growth and increases antibiotic susceptibility of both Mycobacterium bovis BCG and Mycobacterium tuberculosis Microbiology 150 2004 853 864
21. B. Mattioli, L. Giordani, M.G. Quaranta, and M. Viora Effect of indinavir used alone or in double or triple combination with AZT and ddC on human immune functions Life Sci. 74 2004 2291 2300
22. J.C. McKinney, K.H. Bentrup, E.J. Muñoz-Elías, A. Miczak, B. Chen, W.T. Chan, D. Swenson, J.C. Sacchettini, W.R. Jacobs, and D.G. Russell Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase Nature 406 2000 735 738
23. C.L. Mendenhall, F. Finkelman, and R.T. Means Jr. Cytokine response to BCG infection in alcohol fed mice Alcohol 1 1999 57 63
24. S. Mukhopadhyay, and P. Chakrabarti Altered permeability and beta lactam resistance in a mutant of Mycobacterium smegmatis Antimicrob. Agents Chemother. 41 1997 1721 1724
25. T.M. Riddle, N.M. Schildmeyer, C. Phan, C.J. Fichtenbaum, and D.Y. Hui The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice J. Lipid Res. 43 2002 1458 1463
26. J.S. Schorey, M.C. Carroll, and E.J. Brown A macrophage invasion mechanism of pathogenic mycobacteria Science 277 1997 1091 1093
27. R.W. Shafer, and B.R. Edlin Tuberculosis in patients infected with human immune deficiency virus: Perspective on the past decade Clin. Infect. Dis. 22 1996 683 704
28. T.C. Stadtman The microbial metabolism of steroids R. Cook Cholesterol 1958 DC Thomson Editors Dundee 457 463
29. H. Tran, S. Robinson, I. Mikhailenko, and D.K. Strickland Modulation of the LDL receptor and LRP levels by HIV protease inhibitors J. Lipid Res. 44 2003 1859 1869
30. L. Wang, Y. Cai, Q. Cheng, Y. Hu, and H. Xiao Imbalance of Th1/Th2 cytokines in patients with pulmonary tuberculosis Chin. J. Tuberculosis Respir. Dis. 25 2002 535 537